Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
06/2012
06/14/2012WO2012078741A2 Novel fungal esterases
06/14/2012WO2012078656A1 Methods of hydrolyzing oligomers in hemicellulosic liquor
06/14/2012WO2012078311A1 Recombinant bacteria having the ability to metabolize sucrose
06/14/2012WO2012078279A2 Method of microalgal chloroplast transformation using functional selection in the absence of antibiotics
06/14/2012WO2012077817A1 Stabilized enzyme composition and method for producing same
06/14/2012WO2012077684A1 Method for producing sugar
06/14/2012WO2012077614A1 Random transesterification method for fats and oils, and lipase for random transesterification
06/14/2012WO2012077037A2 PEPTIDES THAT MODULATE COMPLEX SASPase-FLG2
06/14/2012WO2012076738A1 Method for the purification and stabilisation of enzyme gluconate dehydrogenase (gadh, ec 1.1.99.3), enzyme gluconate dehydrogenase (gadh, ec 1.1.99.3) and the use of enzyme gluconate dehydrogenase (gadh, ec 1.1.99.3)
06/14/2012WO2012076715A1 Mgmt-based method for obtaining high yield of recombinant protein expression
06/14/2012WO2012076625A1 Modulators of ire1 activity and uses thereof
06/14/2012WO2012075911A1 Use of recombinant human prx-6 protein in treatment of burn and scald and/or corneal injury
06/14/2012WO2012075662A1 Genetically engineered strain producing cutinase and uses thereof
06/14/2012WO2012049179A3 Polypeptides with kinase activity
06/14/2012WO2012049170A3 Pentose and glucose fermenting yeast cell
06/14/2012WO2012049083A3 Novel fucosyltransferases and their applications
06/14/2012WO2012044915A3 Beta-glucosidase variants and polynucleotides encoding same
06/14/2012WO2012004671A3 Meganucleases variants cleaving a dna target sequence in the nanog gene and uses thereof
06/14/2012WO2011153235A3 Compositions featuring superoxide dismutase polypeptides having enhanced anti-oxidant activity
06/14/2012WO2011079048A3 Methods for improving the efficiency of simultaneous saccharification and fermentation reactions
06/14/2012WO2011063308A8 Beta-glucosidase i variants with improved properties
06/14/2012WO2005017135A8 Improved ketoreductase polypeptides and related polynucleotides
06/14/2012US20120151633 Polypeptides having endoglucanase activity and polynucleotides encoding same
06/14/2012US20120151632 Phospholipases and methods of using same
06/14/2012US20120151630 Methods and materials for making and using transgenic dicamba-degrading organisms
06/14/2012US20120151621 Genes for microsomal delta-12 fatty acid desaturases and hydroxylases from plants
06/14/2012US20120149890 Polynucleotides Encoding Thymidine Kinase Mutants
06/14/2012US20120149880 Nucleic Acid Cassette For Producing Recombinant Antibodies
06/14/2012US20120149874 Method for preparing recombinant glycoproteins with high sialic acid content
06/14/2012US20120149768 Pkc-activating compounds for the treatment of neurodegenerative diseases
06/14/2012US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof
06/14/2012US20120149708 Modulators of viral transcription, and methods and compositions therewith
06/14/2012US20120149701 Certain chemical entities, compositions and methods
06/14/2012US20120149682 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
06/14/2012US20120149681 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
06/14/2012US20120149624 Subtilase Variants
06/14/2012US20120149590 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
06/14/2012US20120149115 Targeted genomic rearrangements using site-specific nucleases
06/14/2012US20120149089 Animal product free system and process for purifying a botulinum toxin
06/14/2012US20120149088 Alkylene glycols and polymers and copolymers thereof for direct isolation of nucleic acid from embedded samples
06/14/2012US20120149087 Glucoamylase variants with altered properties
06/14/2012US20120149086 Cutinase-Producing Genetically Engineered Microorganism and Use Thereof
06/14/2012US20120149085 Fusion proteins containing recombinant cytotoxic rnases
06/14/2012US20120149084 Fusion proteins
06/14/2012US20120149083 PEG-Urate Oxidase Conjugates and Use Thereof
06/14/2012US20120149082 Method For The Preparation Of Cross-Linked Enzyme Aggregates With Improved Properties
06/14/2012US20120149078 Polypeptides Having Acetylxylan Esterase Activity And Polynucleotides Encoding Same
06/14/2012US20120149073 Ketoreductase Polypeptides for the Preparation of Phenylephrine
06/14/2012US20120149071 D-aminoacylase
06/14/2012US20120149070 Variants of glucoamylase
06/14/2012US20120149068 Methods and compositions for amplification of rna sequences
06/14/2012US20120149067 Methods for producing hyaluronan in a recombinant host cell
06/14/2012US20120149065 Use of manganese peroxidase for enzymatic hydrolysis of lignocellulosic material
06/14/2012US20120149023 Engineered demeter 5-methylcytosine dna glyosylase with improved yield, stability and solubility
06/14/2012US20120148706 Novel protein having b-glucosidase activity and uses thereof
06/14/2012US20120148657 Lipoxygenase and Its Use in Wound Healing
06/14/2012US20120148599 Methods and compositions for neural disease immunotherapy
06/14/2012US20120148580 Methods for identification of sites for igg conjugation
06/14/2012US20120148572 Novel antibodies
06/14/2012US20120148559 Compositions and method for deimmunization of proteins
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148490 Anti-ngf compositions and use thereof
06/14/2012US20120145544 Novel ubiquitin ligase and use thereof
06/14/2012CA2820630A1 Dimeric molecular complexes with free cysteine residues and conjugates thereof
06/14/2012CA2819810A1 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
06/14/2012CA2819552A1 Mgmt-based method for obtaining high yield of recombinant protein expression
06/13/2012EP2463378A1 Alpha isomaltosylglucosaccharide synthase, process for producing the same and use thereof
06/13/2012EP2463374A2 Isolated alcohol dehydrogenase enzymes and uses thereof
06/13/2012EP2463367A1 Novel ubiquitin ligase and use thereof
06/13/2012EP2463365A1 Probes for detection of UGT1A1 gene, reagent for detection of UGT1A1 gene comprising the same, and uses thereof
06/13/2012EP2463364A1 High fidelity restriction endonucleases
06/13/2012EP2463363A1 High fidelity restriction endonucleases
06/13/2012EP2463299A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
06/13/2012EP2463298A1 Reproductive ablation constructs
06/13/2012EP2462946A1 Method of inhibiting cathepsin activity
06/13/2012EP2462945A2 Method of inhibiting angiogenesis, tumorigenesis and cathepsin activity
06/13/2012EP2462224A1 Method for producing nucleases of a gram negative bacterium while using a gram positive expression host
06/13/2012EP2462223A2 Fructosyl amino acid oxidase
06/13/2012EP2461702A1 Alpha-amylase blend for starch processing and method of use thereof
06/13/2012EP2399927A9 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
06/13/2012EP2094842B1 Novel laccases, compositions and methods of use
06/13/2012EP1824775B1 Debriding composition from bromelain and methods of production thereof
06/13/2012EP1699460B1 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
06/13/2012EP1694847B1 Serine proteases, nucleic acids encoding serine enzymes and vectors and host cells incorporating same
06/13/2012EP1678202B1 Hcv ns3-ns4a protease resistance mutants
06/13/2012EP1609804B1 Construct comprising recognition domain of antibody against von willebrand factor-specific cleaving enzyme
06/13/2012EP1478761B1 Degradation of hydrophobic ester pesticides and toxins
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1183342B2 Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 128 and 129
06/13/2012EP1183338B2 Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 97 and 98
06/13/2012CN1950501B AMP deaminase originating in streptomyces and utilization thereof
06/13/2012CN1930301B Methods for identifying proteins with starch phosphorylating enzymatic activity
06/13/2012CN1823166B Method of measuring glycolated hemoglobin A1C, enzyme to be used therefor and process for producing the same
06/13/2012CN102498207A Storage-stable liquid detergent or cleaning agent containing proteases
06/13/2012CN102492769A Method for identification and purification of intracellular enolase
06/13/2012CN102492710A Beta-glucosidase Cel1b, expression gene and application thereof
06/13/2012CN102492709A Clone and sequence analysis of beta-1, 4-inscribe chitosanase (Aus CsnB) gene
06/13/2012CN102492708A Clone and sequence analysis of beta-1, 4-inscribe xylanase (Aor Xyn10B) gene
06/13/2012CN102492707A Clone and expression of beta-1, 4-inscribe xylanase catalysis domain (Aor Xyn10BC) gene
06/13/2012CN102492706A Gene of Lygus lucorum polygalacturonase and application thereof